Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers.

Literature DB >> 2900827

No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers.

I Ikeda¹, Y Ishizaka, M Ochiai, R Sakai, M Itabashi, M Onda, T Sugimura, M Nagao.

Abstract

The correlation of the restriction fragment length polymorphism (RFLP) pattern of L-myc with the progressive state of cancer and metastases to lymph nodes or other organs were examined in 35 cases of human colorectal cancer by chi 2 analysis. No significant correlation was found.

Entities: Disease Gene Species

Mesh：

Year: 1988 PMID： 2900827 PMCID： PMC5917581 DOI： 10.1111/j.1349-7006.1988.tb02220.x

Source DB: PubMed Journal: Jpn J Cancer Res ISSN： 0910-5050

14 in total

1. Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors: E M Southern
Journal: J Mol Biol Date: 1975-11-05 Impact factor: 5.469

2. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors: T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal: Nature Date: 1985 Jan 31-Feb 6 Impact factor: 49.962

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors: D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal: Science Date: 1987-01-09 Impact factor: 47.728

4. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors: G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal: Science Date: 1984-06-08 Impact factor: 47.728

5. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.

Authors: M Schwab; J Ellison; M Busch; W Rosenau; H E Varmus; J M Bishop
Journal: Proc Natl Acad Sci U S A Date: 1984-08 Impact factor: 11.205

6. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis.

Authors: T Tanaka; D J Slamon; H Shimoda; C Waki; Y Kawaguchi; Y Tanaka; N Ida
Journal: Cancer Res Date: 1988-02-15 Impact factor: 12.701

7. Dominant inheritance of adenomatous colonic polyps and colorectal cancer.

Authors: R W Burt; D T Bishop; L A Cannon; M A Dowdle; R G Lee; M H Skolnick
Journal: N Engl J Med Date: 1985-06-13 Impact factor: 91.245

8. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors: M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal: Nature Date: 1985 Nov 7-13 Impact factor: 49.962

9. Human-tumor-derived cell lines contain common and different transforming genes.

Authors: M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal: Cell Date: 1981-12 Impact factor: 41.582

10. Genetic predisposition to human lung cancer.

Authors: J Heighway; N Thatcher; T Cerny; P S Hasleton
Journal: Br J Cancer Date: 1986-04 Impact factor: 7.640

8 in total

1. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.

Authors: R Dolcetti; S Pelucchi; R Maestro; S Rizzo; A Pastore; M Boiocchi
Journal: Eur Arch Otorhinolaryngol Date: 1991 Impact factor: 2.503

2. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

Authors: I Zborovskaya; A Gasparian; M Kitaeva; B Polotzky; N Tupitzin; Z Machaladze; S Gerasimov; M Shtutman; M Jakubovskaya; M Davidov; A Tatosyan
Journal: Clin Exp Metastasis Date: 1996-11 Impact factor: 5.150

No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers.

1. Detection of specific sequences among DNA fragments separated by gel electrophoresis.

2. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

4. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

5. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.

6. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis.

7. Dominant inheritance of adenomatous colonic polyps and colorectal cancer.

8. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

9. Human-tumor-derived cell lines contain common and different transforming genes.

10. Genetic predisposition to human lung cancer.

1. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.

2. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

3. MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

4. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.

5. Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line.

6. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

7. Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.

8. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.